Full-Time

Head of Regulatory Affairs

Confirmed live in the last 24 hours

Retro Biosciences

Retro Biosciences

51-200 employees

Develops therapeutics targeting aging mechanisms

Biotechnology
Healthcare

Compensation Overview

$170k - $250kAnnually

Senior, Expert

San Carlos, CA, USA

Position requires onsite presence in Redwood City, CA.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • At least 7 years of experience in a Regulatory capacity with experience in drug development
  • At least 3 years of experience working with cell therapies in a regulatory capacity.
  • Proven success advancing therapeutics from pre-IND to first-in-human clinical trial.
  • Experience in supporting the development and implementation of complex regulatory strategies.
  • Experience with clinical trial submissions in the US and proven track record with global regulatory agencies
  • Experience in development, manufacturing, and testing of cell therapeutics is highly desired.
  • Experience developing and documenting regulatory strategies in coordination with clinical plans and marketing objectives.
  • Deep understanding of regulatory requirements in the US and EU for cell and gene therapy and small molecules drug products.
  • Proven success interacting efficiently with Preclinical Research, CMC, and Clinical.
  • The ability to continuously adapt in a dynamic environment with diverse teams and communication styles.
  • Experience effectively communicating the regulatory strategy, issues, and risks in written and verbal format to senior leadership team and other governing bodies.
Responsibilities
  • Lead, define, and manage the strategic regulatory direction for Retro's pipeline.
  • Establish the regulatory pathway to IND filing for our programs.
  • Provide strategic guidance and input related to current regulatory requirements and expectations for cell and gene therapy and small molecules CMC in support of clinical trial and marketing applications.
  • Prepare content and provide regulatory input to key development documents, including clinical protocols, clinical and nonclinical reports and summary documents, statistical analysis plans, etc.
  • Identify, communicate, and propose resolutions to routine and complex strategic issues.
  • Drive workflows related to FDA and foreign regulatory agency interactions (ie, briefing documents and responses to questions).
  • Interface with CMC, nonclinical research, and clinical research aspects of Retro’s programs and help keep stakeholders apprised of new regulations, standards, policies, and guidance issued by domestic and international regulatory authorities.
  • Serve as a liaison between the company and regulatory agencies; serving as primary point of contact for agencies such as the FDA, EMA, TGA, and other global health authorities.
  • Schedule and coordinate meetings (e.g. INTERACT, pre-IND) and oversee the development, compilation, and timely submission of all regulatory documentation to meet program timelines.
  • Develop and coordinate high-quality submissions for clinical trials.
  • Strategize, lead, write, and/or supervise the development and submission of documents or plans (e.g. Orphan, Breakthrough, Fast Track, Accelerated Approval) to regulatory agencies to support development goals.

Retro Biosciences focuses on extending healthy human lifespan by developing therapeutics that target the cellular mechanisms of aging. The company works on three main programs: cellular reprogramming, plasma-inspired therapeutics, and autophagy, each at different stages of development. By addressing the root causes of age-related diseases, Retro Biosciences aims to reduce healthcare costs associated with these conditions, which make up a significant portion of U.S. healthcare spending. The company utilizes advanced technologies like single-cell multi-omics and computational biology to support its research. With $180 million in funding, Retro Biosciences is positioned to advance its therapeutic candidates towards clinical applications, aiming to make significant contributions to age-related disease prevention.

Company Stage

Seed

Total Funding

$175.1M

Headquarters

Redwood City, California

Founded

2021

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

180%
Simplify Jobs

Simplify's Take

What believers are saying

  • Retro Biosciences' mission to extend healthy human lifespan by ten years offers a compelling and impactful vision for employees.
  • The company's robust pipeline and advanced technologies like single-cell multi-omics and computational biology provide ample opportunities for innovation and career growth.
  • Strong financial backing and high-profile investments, such as from Sam Altman, ensure long-term stability and resources for research and development.

What critics are saying

  • The ambitious goal of extending human lifespan by ten years involves high scientific and regulatory uncertainties.
  • Dependence on successful clinical trials and commercialization of therapeutic candidates poses significant risks.

What makes Retro Biosciences unique

  • Retro Biosciences focuses on extending healthy human lifespan by targeting the cellular mechanisms of aging, a unique approach compared to traditional biotech firms.
  • Their diversified business model, which includes cellular reprogramming, plasma-inspired therapeutics, and autophagy, provides a balanced pipeline of potential treatments.
  • Significant initial funding of $180 million and partnerships like the $85 million deal with Multiply Labs for automated cell therapy manufacturing set Retro Biosciences apart in terms of financial backing and technological advancement.

Help us improve and share your feedback! Did you find this helpful?